Eric G. Neilson

Northwestern University — United States

Medicine · Health Sciences

77h-index36.4kcitations297works0.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Renal Diseases and Glomerulopathies(66), Cell Adhesion Molecules Research(36), Nephrotoxicity and Medicinal Plants(32), S100 Proteins and Annexins(23), T-cell and B-cell Immunology(20)

Publications293 total

The Story of Aldosterone Escape
Journal of the American Society of Nephrology·2025Open Access
The Accomplished Life of William G. Couser, MD
Journal of the American Society of Nephrology·2025
Table S3 from S100A4 Is a Biomarker and Regulator of Glioma Stem Cells That Is Critical for Mesenchymal Transition in Glioblastoma
2023Open Access
Table S5 from S100A4 Is a Biomarker and Regulator of Glioma Stem Cells That Is Critical for Mesenchymal Transition in Glioblastoma
2023Open Access
Table S4 from S100A4 Is a Biomarker and Regulator of Glioma Stem Cells That Is Critical for Mesenchymal Transition in Glioblastoma
2023Open Access
Supplementary Methods and figure legends from S100A4 Is a Biomarker and Regulator of Glioma Stem Cells That Is Critical for Mesenchymal Transition in Glioblastoma
2023Open Access
Supplementary Figures from S100A4 Is a Biomarker and Regulator of Glioma Stem Cells That Is Critical for Mesenchymal Transition in Glioblastoma
2023Open Access
Table S5 from S100A4 Is a Biomarker and Regulator of Glioma Stem Cells That Is Critical for Mesenchymal Transition in Glioblastoma
2023Open Access
Table S4 from S100A4 Is a Biomarker and Regulator of Glioma Stem Cells That Is Critical for Mesenchymal Transition in Glioblastoma
2023Open Access
Data from S100A4 Is a Biomarker and Regulator of Glioma Stem Cells That Is Critical for Mesenchymal Transition in Glioblastoma
2023Open Access
Table S3 from S100A4 Is a Biomarker and Regulator of Glioma Stem Cells That Is Critical for Mesenchymal Transition in Glioblastoma
2023Open Access
Table S1 from S100A4 Is a Biomarker and Regulator of Glioma Stem Cells That Is Critical for Mesenchymal Transition in Glioblastoma
2023Open Access
Table S2 from S100A4 Is a Biomarker and Regulator of Glioma Stem Cells That Is Critical for Mesenchymal Transition in Glioblastoma
2023Open Access
Supplementary Methods and figure legends from S100A4 Is a Biomarker and Regulator of Glioma Stem Cells That Is Critical for Mesenchymal Transition in Glioblastoma
2023Open Access
Supplementary Figures from S100A4 Is a Biomarker and Regulator of Glioma Stem Cells That Is Critical for Mesenchymal Transition in Glioblastoma
2023Open Access
Table S2 from S100A4 Is a Biomarker and Regulator of Glioma Stem Cells That Is Critical for Mesenchymal Transition in Glioblastoma
2023Open Access
Data from S100A4 Is a Biomarker and Regulator of Glioma Stem Cells That Is Critical for Mesenchymal Transition in Glioblastoma
2023Open Access
Table S1 from S100A4 Is a Biomarker and Regulator of Glioma Stem Cells That Is Critical for Mesenchymal Transition in Glioblastoma
2023Open Access
Supplementary Figure 2 from Stromal Transforming Growth Factor-β Signaling Mediates Prostatic Response to Androgen Ablation by Paracrine Wnt Activity
2023Open Access
Data from Stromal Transforming Growth Factor-β Signaling Mediates Prostatic Response to Androgen Ablation by Paracrine Wnt Activity
2023Open Access
page 1 of 15Next →

Frequent Co-authors

David Plieth(10), Raghu Kalluri(9), Theodore M. Danoff(7), Masayuki Iwano(6), Hirokazu Okada(6), Michael Zeisberg(5), Chengsen Xue(4), Billy G. Hudson(4), Neil A. Bhowmick(3), Harold L. Moses(3), Fuad N. Ziyadeh(3), Günter Wolf(3), Christo Venkov(3), Carol Xu(3), Anna Chytil(2), Frank Strutz(2), Frank J. Rauscher(2), Vasiliy V. Polosukhin(2), Wei Han(2), Timothy S. Blackwell(2)